These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


127 related items for PubMed ID: 33827085

  • 1. Long Noncoding RNA SPRY4-IT1 Modulates Ketamine-Induced Neurotoxicity in Human Embryonic Stem Cell-Derived Neurons through EZH2.
    Huang J, Xu Y, Wang F, Wang H, Li L, Deng Y, Cai L.
    Dev Neurosci; 2021; 43(1):9-17. PubMed ID: 33827085
    [Abstract] [Full Text] [Related]

  • 2. Overexpression of the long non-coding RNA SPRY4-IT1 promotes tumor cell proliferation and invasion by activating EZH2 in hepatocellular carcinoma.
    Zhou M, Zhang XY, Yu X.
    Biomed Pharmacother; 2017 Jan; 85():348-354. PubMed ID: 27899259
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. LncRNA SPRY4-IT1 facilitates cell proliferation and angiogenesis of glioma via the miR-101-3p/EZH2/VEGFA signaling axis.
    Wang J, Chen Y, Wang Q, Xu H, Jiang Q, Wang M, Li S, Chen Y, Wu C, Yu P, Xiao Z, Chen W, Lan Q.
    Cancer Med; 2023 Mar; 12(6):7309-7326. PubMed ID: 36479622
    [Abstract] [Full Text] [Related]

  • 6. SP1-induced upregulation of lncRNA SPRY4-IT1 exerts oncogenic properties by scaffolding EZH2/LSD1/DNMT1 and sponging miR-101-3p in cholangiocarcinoma.
    Xu Y, Yao Y, Jiang X, Zhong X, Wang Z, Li C, Kang P, Leng K, Ji D, Li Z, Huang L, Qin W, Cui Y.
    J Exp Clin Cancer Res; 2018 Apr 11; 37(1):81. PubMed ID: 29642935
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Long noncoding RNA SPRY4-IT1 promotes proliferation and metastasis of hepatocellular carcinoma via mediating TNF signaling pathway.
    Ma W, Chen X, Wu X, Li J, Mei C, Jing W, Teng L, Tu H, Jiang X, Wang G, Chen Y, Wang K, Wang H, Wei Y, Liu Z, Yuan Y.
    J Cell Physiol; 2020 Nov 11; 235(11):7849-7862. PubMed ID: 31943198
    [Abstract] [Full Text] [Related]

  • 11. Upregulated long non-coding RNA SPRY4-IT1 predicts dismal prognosis for pancreatic ductal adenocarcinoma and regulates cell proliferation and apoptosis.
    Yao Y, Gao P, Chen L, Wang W, Zhang J, Li Q, Xu Y.
    Gene; 2018 Jun 15; 659():52-58. PubMed ID: 29551494
    [Abstract] [Full Text] [Related]

  • 12. LncRNA SPRY4-IT1 regulates breast cancer cell stemness through competitively binding miR-6882-3p with TCF7L2.
    Song X, Zhang X, Wang X, Chen L, Jiang L, Zheng A, Zhang M, Zhao L, Wei M.
    J Cell Mol Med; 2020 Jan 15; 24(1):772-784. PubMed ID: 31736268
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Decreased long non-coding RNA SPRY4-IT1 contributes to ovarian cancer cell metastasis partly via affecting epithelial-mesenchymal transition.
    Yu J, Han Q, Cui Y.
    Tumour Biol; 2017 Jul 15; 39(7):1010428317709129. PubMed ID: 28691641
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Long non-coding RNA SPRY4-IT1 promotes cell proliferation and invasion by regulation of Cdc20 in pancreatic cancer cells.
    Guo W, Zhong K, Wei H, Nie C, Yuan Z.
    PLoS One; 2018 Jul 15; 13(2):e0193483. PubMed ID: 29489909
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. High expression of long non-coding RNA SPRY4-IT1 predicts poor prognosis of clear cell renal cell carcinoma.
    Zhang HM, Yang FQ, Yan Y, Che JP, Zheng JH.
    Int J Clin Exp Pathol; 2014 Jul 15; 7(9):5801-9. PubMed ID: 25337221
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.